Ilyang Brand Ranking
Industry: ibuprofen suspension , drug
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Ilyang

Ilyang

Yangzhou Yiyang Pharmaceutical Co., Ltd.
Industry: ibuprofen suspension , drug
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Yangzhou Yiyang Pharmaceutical Co., Ltd. is located in Gaoyou Economic Development Zone, Jiangsu Province, covering an area of ​​nearly 100 acres. It is a modern pharmaceutical enterprise established on June 28, 1994 by South Korea Yiyang Pharmaceutical Co., Ltd. and Gaoyou Industrial Corporation.

The company officially started production on July 8, 1998. In the same year, the three production lines of powder injection, tablets and suspensions all passed the national GMP certification, and are one of the enterprises in the country that have passed the national GMP certification.

The main products include a unique new type of neutralizing gastric acid drug aluminum magnesium plus suspension ("Anda"), ibuprofen suspension, and a compound treatment for symptoms caused by insufficient bile secretion or lack of digestive enzymes. Zimmite enteric-coated tablets ("Mitte"), powder injection lysin ("Asagir", imported raw material) and other products.

The main production equipment of the preparation workshop is introduced from Italy, South Korea, etc., with complete testing equipment, with hardware conditions that match the production products and a complete quality assurance system. The product sales network covers the whole country.

Over the years, the company's operations have been operating healthily and healthily. In order to meet the continuous market demand, the company invested nearly 100 million yuan in 2013 to implement technical transformation. From September 2014 to May 2015, a new comprehensive preparation workshop (powder injection workshop and tablet workshop are built. , inspection center and warehousing, etc.) have passed the GMP (2010 version) certification and put into production; a new suspension workshop will be built in September 2018, and it is expected to be put into production and use in 2020. While the production scale continues to expand, the company has cooperated with foreign parties to develop a number of new products such as anti-leukemia drugs according to market needs, and R&D work is underway.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号